Paul E Freiman Net Worth & Insider Trades

Paul E Freiman - Director, Novabay Pharmaceuticals, Inc

As of May 24, 2022

What is Paul E Freiman's Net Worth?

The current estimated net worth of Novabay Pharmaceuticals, Inc's Director, Paul E Freiman, is estimated to be about $92.44K . Paul E Freiman owns about 15,137 units of Novabay Pharmaceuticals, Inc common stock. In the last 13 years at Novabay Pharmaceuticals, Inc, Paul E Freiman has sold an estimated value of $85.7K worth.

What is Paul E Freiman's Past Insider Trading?

Paul E Freiman's largest purchase order was 3,000 units , worth over $2.52K on September 13, 2011. Paul E Freiman's largest sale order was 25,000 units , worth over $58.25K on June 15, 2009. In total, Paul E Freiman has made about 19 transactions over 13 years of their time at Novabay Pharmaceuticals, Inc. Paul E Freiman usually trades in May, with the busiest year in 2009.

Paul E Freiman

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is Paul E Freiman's' Mailing Address?

  • Mailing address is C/o Novabay Pharmaceuticals, Inc. 5980 Horton Street, Suite 550 Emeryville CA 94608 CA

What are Novabay Pharmaceuticals, Inc's Past Insider Trades?

Novabay Pharmaceuticals, Inc's most recent insider trade came on December 7, 2022 by Audrey Kunin who sold 1 unit worth $1.81 . In the last 15 years, insiders at Novabay Pharmaceuticals, Inc have sold an estimated value of $3.89M and bought an estimated value of $43.61M worth of shares. Insider trading is most common in January, with the busiest year in 2009. The most active traders at the company are Paul E Freiman, Director,  Ramin Najafi, Chief Executive Officer,  and Robert Tufts, Director .

NovaBay Pharmaceuticals, Inc. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1